Search for Articles

Article

1 Citations

1,071 Views

11 Pages

Cost Analysis of PSMA-PET in the PROSPET-BX Trial

Egesta Lopci,
Cesare Saitta,
Alberto Saita,
Elena Vanni and ,
Alessandro Santandrea,
Luca Disconzi,
Vittorio Fasulo,
Nicolò Buffi,
Massimo Lazzeri and
Giovanni Lughezzani
+ 5 authors+ 0 author

Cancers2026, 18(5), 806;https://doi.org/10.3390/cancers18050806

2 March 2026

Background: The PROSPET-BX trial compared [⁶⁸Ga]PSMA-11 PET/CT (PSMA-PET) with multiparametric MRI (mpMRI) in parallel in men with suspicion of prostate cancer (PCa) after at least one previously negative biopsy (ClinicalTrials.gov: NCT05297162; GR-2...

(This article belongs to the Special Issue Cancer Treatment: Present and Future of Radioligand Therapy)

Full Article

1 Result Found

Cost Analysis of PSMA-PET in the PROSPET-BX Trial